Haase KD - Search Results

1

Interferon-gamma treatment of metastasized malignant melanoma.

Haase KD, Lange OF, Scheef W. Haase KD, et al. Anticancer Res. 1987 May-Jun;7(3 Pt B):335-6. Anticancer Res. 1987. PMID: 3115173

2

Simultaneous radiotherapy and chemotherapy in the treatment of brain metastases of malignant solid tumours.

Lange OF, Schlechtingen J, Haase KD, Scheef W. Lange OF, et al. Among authors: haase kd. Int J Clin Pharmacol Res. 1987;7(5):427-32. Int J Clin Pharmacol Res. 1987. PMID: 3667011

3

Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer. Results of a prospective multicenter trial.

Lange OF, Scheef W, Haase KD, Heckmann M, Leyendecker R, Urban G, Zegners G. Lange OF, et al. Among authors: haase kd. Cancer Chemother Pharmacol. 1990;26 Suppl:S74-7. doi: 10.1007/BF00685427. Cancer Chemother Pharmacol. 1990. PMID: 1693317 Clinical Trial.

4

Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience.

Lange OF, Scheef W, Haase KD. Lange OF, et al. Among authors: haase kd. Cancer Chemother Pharmacol. 1990;26 Suppl:S78-80. doi: 10.1007/BF00685428. Cancer Chemother Pharmacol. 1990. PMID: 1693318

5

Simultaneous radio- and chemotherapy of inoperable brain tumours.

Lange OF, Haase KD, Scheef W. Lange OF, et al. Among authors: haase kd. Radiother Oncol. 1987 Apr;8(4):309-14. doi: 10.1016/s0167-8140(87)80180-9. Radiother Oncol. 1987. PMID: 3588993

6

Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG).

Seegenschmiedt MH, Sauerbrei W, Sauer R, Schumacher M, Schauer A, Rauschecker HF, Dinkloh H, Dühmke E, Haase KD, Haase W, et al. Seegenschmiedt MH, et al. Among authors: haase kd. Strahlenther Onkol. 1993 Jun;169(6):339-50. Strahlenther Onkol. 1993. PMID: 8316938 Clinical Trial.

7

Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy.

Habermehl D, Haase K, Rieken S, Debus J, Combs SE. Habermehl D, et al. Tumori. 2011 Sep-Oct;97(5):609-13. doi: 10.1177/030089161109700512. Tumori. 2011. PMID: 22158492

8

Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.

Habermehl D, Lindel K, Rieken S, Haase K, Goeppert B, Büchler MW, Schirmacher P, Welzel T, Debus J, Combs SE. Habermehl D, et al. Strahlenther Onkol. 2012 Sep;188(9):795-801. doi: 10.1007/s00066-012-0099-y. Epub 2012 Apr 13. Strahlenther Onkol. 2012. PMID: 22526232 Clinical Trial.

9

Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.

Throup A, Zraikat MS, Gordon A, Jafarinejad Soumehsaraei S, Haase KD, Patterson LH, Cooper PA, Hanlon K, Loadman PM, Sutherland M, Shnyder SD, Sheldrake HM. Throup A, et al. Among authors: haase kd. RSC Med Chem. 2024 Sep 13;15(10):3616-24. doi: 10.1039/d4md00306c. Online ahead of print. RSC Med Chem. 2024. PMID: 39281803 Free PMC article.

10

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H. Henke M, et al. Among authors: haase kd. Lancet. 2003 Oct 18;362(9392):1255-60. doi: 10.1016/S0140-6736(03)14567-9. Lancet. 2003. PMID: 14575968 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters